Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for CMPX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 190.17M
March 31, 2026 205.17M
December 31, 2025 222.15M
September 30, 2025 231.26M
June 30, 2025 116.70M
March 31, 2025 131.45M
December 31, 2024 140.40M
September 30, 2024 149.15M
June 30, 2024 155.61M
March 31, 2024 161.14M
December 31, 2023 156.88M
September 30, 2023 170.04M
June 30, 2023 179.18M
March 31, 2023 187.98M
Date Value
December 31, 2022 199.64M
September 30, 2022 127.84M
June 30, 2022 140.26M
March 31, 2022 146.56M
December 31, 2021 153.76M
September 30, 2021 34.90M
June 30, 2021 40.87M
March 31, 2021 48.20M
December 31, 2020 51.91M
September 30, 2020 60.69M
June 30, 2020 70.45M
March 31, 2020 22.28M
December 31, 2019 30.38M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Upstream Bio, Inc. 281.17M
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M

Total Assets (Quarterly) Related Metrics